Carbon tetrachloride suppresses T-cell-dependent immune responses by induction of transforming growth factor-β1

Toxicology and Applied Pharmacology

Volumn 126, Issue 1, 1994, Pages 98-107

  Delaney, Bryan ^a   Strom, Stephen C ^a   Collins, Sharon ^a   Kaminski, Norbert E ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOTOXICITY; MOUSE; NONHUMAN; T LYMPHOCYTE;

ANIMAL; ANTIBODY-PRODUCING CELLS; CARBON TETRACHLORIDE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; MICE; MICE, INBRED STRAINS; RECEPTORS, INTERLEUKIN-2; SPLEEN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0028290879     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1006/taap.1994.1095     Document Type: Article

References (56)

1. Annoni, G., Weiner, F. R., and Zern, M. A. (1992). Increased transforming growth factor-β1 gene expression in human liver disease. J. Hepatol 14, 259-264.
2. Armendariz-Borunda, J., Seyer, J. M., Kang, A. H., and Raghow, R. (1990). Regulation of TGF-β gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J. 4, 215-221.
3. Bartlett, M. S. (1937). Sub-sampling for attributes. J. R. Slat. Soc. (Suppl.) 4, 131.
4. Braun, L., Mead, J. E., Panzica, M., Mikumo, R., Bell, G. I., and Fausto, N. (1988). Transforming growth factor β mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation. Proc. Natl. Acad. Sci. USA 85, 1539-1543.
5. Carr, B. I., Hayashi, I., Braun, E. L., and Moses, H. L. (1986). Inhibition of DNA synthesis in rat hepatocytes by platelet derived type β transforming growth factor. Cancer Res. 46, 2330-2334.
6. Coffmann, R. L., Lebman, D. A., and Shrader, B. (1989). Transforming growth factor-β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170, 1039-1044.
7. Conner, H. D., Lacagnin, L. B., Knecht, K. T., Thurman, R. G., and Mason, R. P. (1990). Reaction of glutathione with a free radical metabolite of carbon tetrachloride. Mol. Pharmacol. 37, 443-451.
8. Coutinho, A., Larsson, E.-L., Gronvik, K.-O., and Andersson, J. (1979). Studies on T lymphocyte activation. II. The target cells for concanavalin A-induced growth factors. Eur. J. Immunol. 9, 587-592.
9. Creely, J. J., Dimari, S. J., Howe, A. M., and Haralson, M. A. (1992). Effects of transforming growth factor-β on collagen synthesis by normal rat kidney epithelial cells. Am. J. Pathol. 140, 45-55.
10. Cross, D., and Cambier, J. C. (1990). Transforming growth factor-β1 has differential effects on B cell proliferation and activation antigen expression. J. Immunol. 144, 432-439.
11. Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, M.-E., Wind, R., Biempica, L., and Zern, M. A. (1989). In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell. Biol. 108, 2477-2482.
12. Delaney, B., and Kaminski, N. E. (1993a). High concentrations of 1L-2 selectively suppress T-cell dependent humoral immune responses. Immunopharmacology 26, 119-127.
13. Delaney, B., and Kaminski, N. E. (1993b). Induction of serum borne immunomodulatory factors in B6C3F1 mice by carbon tetrachloride. I. carbon tetrachloride-induced suppression of helper T lymphocyte function is mediate by serum borne factors. Toxicology 85, 67-84.
14. Dunnett, C. W. (1955). A multiple comparison procedure for comparing several treatments with a control. J Am. Stat. Assoc. 50, 1096-1121.
15. Ellingsworth, L. R., Nakayama, D., Segarini, P., Dasch, J., Carrillo, P., and Waegell, W. (1988). Transforming growth factor-βs are euipotent growth inhibitors of interleukin-1-induced thymocyte proliferation. Cell. Immunol 114, 41-54.
16. Elliott, J. F., Lin, Y., Mizel, S. B., Bleakley, R. C., Harnish, D. G., and Paetkau, V. (1984). Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science 236, 1439-1441.
17. Fargeas, C, Wu, C Y., Nakajima, T., Cox, D., Nutman, T., and Dele-spesse, G. (1992). Differential effect of transforming growth factor-β on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes. Eur. J. Immunol. 22, 2173-2176.
18. Freed, B. M., Lempert, N., and Lawrence, D. A. (1991), Inhibition of interleukin-2 production in the human T cell line Jurkat by nonpolar maleimides. Toxicol. Appl. Pharmacol. 107, 173-182.
19. Gehan-Wilcoxon Test (1975). In Survival Distributions: Reliability Applications in the Biomedical Sciences. (A. J. Gross and V. A. Clark, Eds.), pp. 102-123. Wiley, New York.
20. Gillis, S., Ferm, M. M., Ou, W., and Smith, K. A. (1978). T-cell growth factor: Parameters of production and quantitative microassay for activity. J. Immunol. 120, 2027-2032.
21. Heine, W. D. (1980). Proliferation kinetics of Kupffer cells. In The Reticuloendothelial System and the Pathogenesis of Liver Disease (H. Liehr and M. Gron. Eds.), pp. 22-44. Elsevier, Amsterdam.
22. Houck, K. A., Cruise, J. L., and Michalopoulos, G. (1988). Norepinephrine modulated the growth-inhibitory effect of transforming growth factor-β in primary rat hepatocyte cultures. J. Cell. Physiol. 135, 551-555.
23. House, R. V., Lauer, L. D., Murray, M. J., and Dean, J. D. (1987). Suppression of T-helper cell function in mice following exposure to the carcinogen 7, 12-dimethylbenzanthracene and its restoration by interleukin-2. Int. J. Immunopharmacol. 9, 89-97.
24. Kaminski, N. E., Barnes, D. W., Jordan, S. D., and Holsapple, M. P. (1990). The role of metabolism in carbon tetrachloride-mediated immunosuppression: In vivo studies. Toxicol. Appl. Pharmacol. 102, 9-20.
25. Kaminski, N. E., Jordan, S. D., and Holsapple, M. P. (1989). Suppression of humoral and cell-mediated immune responses by carbon tetrachloride. Fundam. Appl. Toxicol. 12, 117-128.
26. Kehrl, J. H., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B., and Fauci, A. S. (1988). Transforming growth factor-β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137, 3855-3860.
27. Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-mon, M., Derynk, R., Sporn, M. B., and Fauci, A. S. (1986). Production of transforming growth factor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163, 1037-1050.
28. Kim, P. H., and Kagnoff, M. F. (1990). Transforming growth factor-β is a costimulator for IgA production. J. Immunol. 144, 3411-3416.
29. Lacagnin, L. B., Conner, H. D., Mason, R. P., and Thurman, R. G. (1988).The carbon dioxide anion radical adduct in the perfused rat liver: Relationship to halocarbon-induced toxicity. Mol. Pharmacol. 33, 351-357.
30. Ladies, G. S., Kawbata, T. T., Munson, A. E., and White, K. L., Jr. (1992). Evaluation of murine splenic cell type metabolism of benzo[a]pyrene and functionality in vitro following repeated in vivo exposure to benzo[a]pyrene. Toxicol. Appl. Pharmacol. 116, 258-266.
31. Lee, G., Ellingsworth, L. R., Gillis, S., Wall, R., and Kincade, P. W. (1987). β Transforming growth factors are potential regulators of B lymphocytes. J. Exp. Med. 166, 1290-1299.
32. Lee, H.-M., and Rich, S. (1991). Co-stimulation of T-cell proliferation by transforming growth factor-β1. J. Immunol. 147, 1127-1133.
33. Link, B., Durk, H., Thiel, D., and Frank, H. (1984). Binding of trichloromethyl radicals to lipids of the hepatic endoplasmic reticulum during tetrachloromethane metabolism. Biochem. J. 223, 577-586.
34. Michalopoulos, G. K. (1990). Liver regeneration: Molecular mechanisms of growth control. FASEB J. 4, 176-187.
35. Nagy, P., Schaff, Z., and Lapis, K. (1991). Immunohistochemical detection of transforming growth factor-β1 in fibrotic liver diseases. Hepatology 14, 269-273.
36. Nakamura, T., Tomita, Y., Hirai, R., Yamaoka, K., Kaji, K., and Ichihara, A. (1985). Inhibitory effect of transforming growth factor-β on DNA synthesis of rat adult hepatocytes in primary cell culture. Biochem. Biophys. Res. Commun. 133, 1042-1050.
37. Nakatsukasa, H., Evarts, R. P., Hsia, C.-C, Marsden, E., and Thorgeirsson, S. S. (1991). Expression of transforming growth factor-β1 during chemical carcinogenesis in the rat. Lab Invest. 65, 511-517.
38. Nakatsukasa, H., Evarts, R. P., Hsia, C.-C., and Thorgeirsson, S. S. (1990a). Transforming growth factor-β 1 and type I procollagen transcripts during liver regeneration and early fibrosis of rat liver. Lab. Invest. 63, 171-180.
39. Nakatsukasa, H., Nagy, P., Evarts, R. P., Hsia, C.-C, Marsden, E., and Thorgeirsson, S. S. (1990b). Cellular distribution of transforming growth factor-β1 and procollagen types 1, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J. Clin. Invest. 85, 1833-1843.
40. 2) with amino acids: Pulse radiolysis evidence. Life Sci. 23, 2617-2620.
41. Post, G. B., Snyder, R., and Kalf, G. F. (1985). Inhibition of RNA synthesis and interleukin-2 production in lymphocytes in vitro by benzene and its metabolites hydroquinone and p-benzoquinone. Toxicol. Lett. 29, 161-167.
42. Recknagel, R. O. (1967). Carbon tetrachloride hepatotoxicity. Pharmacol. Rev. 19, 145-208.
43. Recknagel, R. O., and Glende, E. A., Jr. (1973). Carbon tetrachloride hepatotoxicity: An example of lethal cleavage. CRC Crit. Rev. Toxicol. 2, 263-297.
44. Recknagel, R. O., and Glende, E. A., Jr. (1977). Lipid peroxidation: A specific form of cellular injury. In Handbook of Physiology (D. H. K. Lee, Ed.), Section 9. pp. 591-601, American Physiology Society, BeIhesda, MD; Williams and Wilkins, Baltimore, MD.
45. Rojkind, M., and Valadez, G. (1985). Regulation of proliferation of fibroblast proliferation by Kupffer cells and monocytes. In Fibrosis (Ciba Foundation, Eds.), pp. 208-221, Pitman, London.
46. Rook, A. H., Kehrl, K. H., Wakefield, L. M., Roberts, A. B., Sporn, M. B., Burlington, D. B., Lane, H. C, and Fauci, A. S. (1986). Effects of transforming growth factor-β1 on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136, 3916-3920.
47. Ruegemer, J. J., Ho, S. N., Augustine, J. A., Schlager, J. W., Bell, M. P., McKean, D. J., and Abraham, T. R. (1990). Regulatory effects of transforming growth factor-β on IL-2- and IL-4-dependent T cell-cycle progression. J. Immunol. 144, 1767-1776.
48. Russell, W. E., Coffey, R. J., Jr., Quellette, A. J., and Moses, H. L. (1988). Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA.85, 5126-5130.
49. Siepl, C, Bodmer, S., Frei, K., MacDonald, H. R., Demartin, R., Hofer, E., and Fontana, A. (1988). The glioblastoma-derived suppressor factor/transforming growth factor-β2 inhibits T-cell growth without affecting the interaction of interleukin 2 with its receptor. Eur. J. Immunol. 18, 593-600.
50. Stoeck, M., Howe, R. C, Mieschler, S., Von Fliedner, V., and MacDonald, H. R. (1990). Effect of transforming growth factor beta on the EL4 thymoma variant EL4/6.1: Dissociation of inhibition of proliferation from expression of IL-1 and IL-2 receptors. Immunobiol. 181, 13-21.
51. Stoeck, M., Miescher, S., MacDonald, H. R., and Von Fleidner, V. (1989). Transforming growth factors beta slow down cell-cycle progression in a murine interleukin 2 dependent T-cell line. J. Cell Physiol. 141, 65-73.
52. Strain, A. J., Frazer, A., Hill, D. J., and Milner, R. D. G. (1987). Transforming growth factor β inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem. Biophys. Res. Commun. 145, 436-442.
53. Swain, S. L., Huston, G., Tonkonogy, S., and Weinberg, A. (1991). Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147, 2991-3000.
54. Trudell, J. R., Bosterling, B. and Trevor, A. J. (1982). Reductive metabolism of carbon tetrachloride by human cytochromes P450 reconstituted in phospholipid vesicles: Mass spectral identification of trichloromethyl radical bound to dioleoyl phosphatidylcholine. Proc. Natl. Acad. Sci. USA 79, 2678-2682.
55. Wahl, S. M., Hunt, D. A., Wong, H. L., Dougherty, S., McCartney-Francis, N., Wahl, L. M., Ellingsworth, L., Schmidt, J. A., Hall, G., Roberts, A. B., and Sporn, M. B. (1988). Transforming growth factor-β is a potent immunosuppressive agent that inhibits IL-1 -dependent lymphocyte proliferation. J. Immunol. 140, 3026-3032.
56. Wakefield, L. M., Smith, D. M., Masui, T., Harris, C. C, and Sporn, M. B. (1987). Distribution and modulation of the cellular receptor for transforming growth factor-beta. J. Cell. Biol. 105, 965-975.